Skip to main content
. 2022 Mar 28;14(2):140–147. doi: 10.5114/jcb.2022.114990

Table 1.

Clinical characteristics of patients (n = 28)

Item n (%)
Age (years) 64 (45-72)
Sex
Male 16 (57.1)
Female 12 (42.9)
Karnofsky performance scale
70 15 (53.6)
80 11 (39.3)
90 2 (7.1)
Diagnosis
Inoperable pancreatic adenocarcinoma 25 (89.3)
Recurrent pancreatic adenocarcinoma 3 (10.7)
Tumor location
Head of the pancreas 18 (64.3)
Body and tail of the pancreas 10 (35.7)
Size of the lesions (cm) 3.2-5.2
TNM stage
Stage IIB 9 (32.1)
T2N1M0 2 (7.1)
T3N1M0 7 (25.0)
Stage III 19 (67.9)
T4N0M0 6 (21.4)
T4N1M0 13 (46.0)
Pain intensity 25 (89.3)
Severe 8 (28.6)
Moderate 11 (39.3)
Mild 6 (21.4)
Previous treatment
Radiotherapy 3 (10.7)
Percutaneous trans-hepatic cholangial drainage/biliary stenting 2 (7.2)
None 23 (82.1)

TNM – tumor/node/metastasis